...
Свидетельство о регистрации ПИ №ФС77-235В7
от 8 марта 2008 г. ISSN: 1815-445X
от 8 марта 2008 г. ISSN: 1815-445X
The effect of mesenchymal stromal cells and the mobilization of stem cells in bone marrow on the development of nephrosclerosis
К сожалению PDF статьи на данный момент не доступен.
Volume V, №2, 20101. State Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk, Russia
2. State Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk, Russia
3. Novosibirsk Research Institute of Tuberculosis, Novosibirsk, Russia
2. State Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk, Russia
3. Novosibirsk Research Institute of Tuberculosis, Novosibirsk, Russia
Keywords:
nehprosclerosis, mesenchymal stromal cell, hematopoietic cell mobilization
nehprosclerosis, mesenchymal stromal cell, hematopoietic cell mobilization
The effects of autologous mesenchymal stromal cell (MSC) transplantation and of bone marrow (BM) hematopoietic cells mobilization on the course of rhabdomyolysis-induced nephropathy in mice were studied. Both MSC transplantation and mobilization of hematopoietic BM cells were demonstrated to improve function and to inhibit fibrotic transformation of the kidney. At the same time MSC transplantation had no impact on the levels of mononuclear infiltration and on the casts formation, but decreased systemic proinflammatory responsiveness. Mobilization of BM hematopoietic cells, on the contrary, enhanced the levels of mononuclear infiltration and casts formation in renal tissue, but did not alter the systemic proinflammatory responsiveness. Both MSC transplantation and BM hematopoietic cells mobilization were concluded to be the most promising approaches to the development of novel therapeutic methods to treat progressive nephropathy.
К сожалению, только зарегистрированные пользователи могут оставлять комментарии.
1. Chatziantoniou С, Dussaule J-C. Insight into the mechanisms of renal fibrosis: is it possible to achieve regression? Am. J. Physiol. Renal. Physiol. 2005; 289: 227-34.
2. Yu H.T. Progression ofchronic renal failure. Arch. Intern. Med. 2003; 163: 1417-29.
3. KisselevaT., Brenner D.A. Mechanisms of fibrogenesis. Exp. Biol. Med. 2008; 233: 109-22.
4. Boor P., Sebekova K., Ostendorf Т., Floege J. Treatment target in renal fibrosis. Nephrol. Dial. Transplant. 2007; 22: 3391-407.
5. Parmar M.S. Chronic renal disease. BMJ 2002; 325: 85-90.
6. Togel F., Hu Z., Weis K. et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal. Physiol. 2005; 289: 31-42.
7. Morigi M., Imberti В., Zola С et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-804.
8. Bi В., Schmitt R., Israilova H. et al. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007; 18: 2486-96.
9. Togel F., Weiss K., Yang Y. et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal. Physiol. 2007; 292: 1626-35.
10. Morigi M., Introna M., Imberti B. et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-82.
11. H.Herrera M.B., Bussolati В., Bruno S. et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International 2007; 72: 430-41.
12. Poulson R., Alison M.A., Cook T. et al. Bone marrow stem cells contribute to healing of the kidney. J. Am. Soc. Nephrol. 2003; 14: 48-54.
13. Guo J-K., Schedl A., Krause D.S. Bone marrow transplantation can attenuate the progression of mesangial sclerosis. Stem Cells 2006; 24: 406-15.
14. Burne-Taney M.J., Kofler J., Yokota N. et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am. J. Physiol. Renal. Physiol. 2003; 285: 87-94.
15. Rabb H. Immune modulation of acute kidney injury. J. Am. Soc. Nephrol. 2006; 17: 604-6.
16. Jo S-K., Sung S-A., Cho W-Y. et al. Macrophages contribute to the initiation of ischemic acute renal failure in rats. Nephrol. Dial. Transplant. 2006; 21: 1231-9.
17. Zager R.A., Johnson A.C.M., Lung S. et al. Acute renal failure: determinants and characteristics of the injury-induced hyperinf lammatory response. Am. J. Physiol. Renal. Physiol. 2006; 291: 546-56.
18. Catania J.M., Chen G., Parrish A.R. Role of metalloproteinases in renal pathophisiologies. Am. J. Physiol. Renal. Physiol. 2007; 292: 905-11.
19. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal sells. Blood 2007; 110: 3499-506.
20. Kruglyakov P.V., Lohmatova E.A., Klimovich V.V., Zarickij A.Ju. Mezenhimal'nye stvolovye kletki i immunopatologicheskie sostoyaniya organizma. Kletochnaya transplantologiya i tkanevaya inzheneriya 2008; 3(5): 36-41.
21. Iwasaki М., Adachi Y., Minamino К. et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-indused renal failure, and M-CSF enhances the effect of G-CSF.J. Am. Soc. Nephrol. 2005: 16: 658-66.
22. Togel F., Isaac J., Westenfelder С Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1261-7.
23. Stokman G., Leemans J.C., Claessen N., Weening J.J., Florquin S. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J. Am. Soc. Nephrol. 2005; 16: 1684-92.
24. Kurtz T.W., Maletz R.M., Hsu C.H. Renal cortical blood flow in glycerol-induced acute renal failure in the rat. Circ. Res. 1976; 38: 30-35.
25. Lieberthal W., Nigam S.K. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am. J. Physiol. Renal Physiol. 2000; 278: 1-12.
26. Zager R.A., Jonson A.C., Lund S. et al. Acute renal failure: determinants and characteristics of injury-induced hyperinflammatory response. Am. J. Physiol. Renal Physiol. 2006; 291: 546-56.
27. Shestobaev E.Ju., Kaplya O.A., Zueva E.P., Razina T.G. Funkcional'naya aktivnost' peritoneal'nyh makrofagov pri razvitii karcinomy legkih L'jus na fone primeneniya jekstrakta shlemnika bajkal'skogo i ciklofosfana. Sibirskij onkologicheskij zhurnal 2004; 4: 37-41.